Why the study?
Does the combination of continuous 12-lead ECG and troponin T improve risk stratification in patients with chest pain and a non-diagnostic ECG?
Does the combination of continuous 12-lead ECG and troponin T improve risk stratification in patients with chest pain and a non-diagnostic ECG?
The combination of continuous 12-lead ECG monitoring and troponin T testing during the first 6 hours effectively stratifies risk for 30-day cardiac death or MI in patients with chest pain and non-diagnostic ECGs.
No takes yet. Share an insight, caveat, or question.
Supports combined troponin T and continuous ECG for stratification in chest pain; hypothesis-generating, prospective validation needed before practice change.
Tomas Jernberg (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: